Buy Vilon Lymphocyte Activity For Sale

Direct Answer: Sourcing High-Purity Vilon for Lymphocyte Activity Assays

Researchers seeking to buy Vilon for lymphocyte activity experiments require a ultra-pure, non-pyrogenic short peptide capable of delivering consistent data across in vitro cell culture and animal tissue assays. Vilon (L-lysyl-L-glutamic acid) is a synthetic short bioregulatory dipeptide originally derived from computer modeling of thymic polypeptide extracts, designed to target gene transcription and chromatin condensation in aging or senescent immune cells.

When purchasing research-grade Vilon peptide for laboratory use, analytical purity and precise sequence verification are paramount. In cellular assays, even minor peptide impurities, salt residues, or bacterial endotoxins can alter cytokine secretion, induce non-specific cell death, or obscure flow cytometry markers. PX1 Research provides fully characterized Vilon dipeptide produced in ISO 17025-accredited and GMP-compliant facilities, verified per lot via reversed-phase high-performance liquid chromatography (RP-HPLC) and liquid chromatography-mass spectrometry (LC-MS).

Molecular Identity and Chemical Properties of Vilon (Lys-Glu)

Vilon is one of the shortest functional bioregulatory peptides synthesized to date, consisting of a simple dipeptide sequence: L-lysyl-L-glutamic acid (Lys-Glu, or KE). With a molecular formula of C11H21N3O5 and a molecular weight of approximately 275.3 g/mol, its minimal size allows for rapid molecular diffusion and potential direct cellular uptake or nuclear translocation during molecular binding experiments.

Despite its simple primary structure, the polar and ionic nature of its side chains (a positively charged amino group on lysine and a negatively charged carboxyl group on glutamic acid) endows Vilon with distinct binding affinity to specific DNA sequences and histone tails. In computational modeling and biophysical assays, the Lys-Glu motif interacts directly with the major and minor grooves of double-stranded DNA, specifically targeting heterochromatin regions to promote euchromatin formation.

To ensure reproducible assay conditions across experimental replicates, laboratories must utilize Vilon synthesized via solid-phase peptide synthesis (SPPS) that yields a single, highly purified TFA-counterion or acetate salt form. The complete catalog of research peptides at PX1 Research adheres to these strict chemical specifications to avoid variable ionic strength in sensitive cellular buffers.

Preclinical Evidence: Vilon and Lymphocyte Chromatin Remodeling

In vitro and ex vivo investigations demonstrate that Vilon exerts primary regulatory effects on the architecture of nuclear chromatin within human and rodent lymphocytes. During cellular aging or immunosenescence, heterochromatin regions expand, leading to the epigenetic silencing of key genes required for T-cell activation, differentiation, and receptor expression. Preclinical studies suggest that exposure to nanomolar concentrations of Vilon induces localized chromatin decondensation (unpacking) in peripheral blood lymphocytes derived from elderly donors.

Fluorometric and microfluorometric assays reveal that Vilon triggers the reactivation of silenced ribosomal RNA (rRNA) genes within nucleoli, as evidenced by increased silver-staining nucleolar organizer regions (AgNORs). This decondensation process enables RNA polymerase I accessibility, restoring ribosomal biogenesis and protein synthesis capacity in previously quiescent or senescent T-lymphocyte populations.

Furthermore, epigenetic analysis in preclinical models indicates that Vilon modulates histone acetylation patterns. By enhancing histone acetyltransferase (HAT) activity or suppressing specific histone deacetylases (HDACs), the dipeptide promotes an open chromatin conformation that facilitates transcription factor binding at promoter regions of immune-related genes. Researchers investigating these mechanisms can consult our detailed bioregulatory peptide mechanism guide for deeper literature references.

T-Cell Differentiation, Cytokine Signaling, and Immunogerontology Models

The impact of Vilon on functional lymphocyte activity extends beyond structural chromatin alterations to encompass cell-surface receptor expression and cytokine secretion profiles. In vitro culture models utilizing splenocytes and thymocytes demonstrate that Vilon exposure influences the differentiation pathways of naive CD4+ helper T-cells and CD8+ cytotoxic T-lymphocytes.

Specifically, research indicates that Vilon administration to primary lymphocyte cultures upregulates the expression of interleukin-2 (IL-2) and its high-affinity receptor subunit (CD25). IL-2 signaling is crucial for clonal expansion and survival of T-cells following antigen recognition. In murine models of induced immunodeficiency or natural aging, treatment with Vilon restored the CD4+/CD8+ cell ratio toward baseline youthful control levels, suggesting a protective role against thymic involution and immune degradation.

Additionally, flow cytometric assays indicate that Vilon suppresses excessive inflammatory signaling while promoting balanced immune homeostasis. In lipopolysaccharide (LPS)-stimulated macrophage and lymphocyte co-culture systems, Vilon attenuated peak tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) release, demonstrating a dual regulatory mechanism that balances activation with anti-inflammatory homeostasis.

Comparative Analysis: Short Bioregulators in Immune Research

Vilon belongs to a distinct class of ultra-short peptide bioregulators developed to target specific organ systems and nuclear structures. When designing immunological assays, researchers often compare Vilon against other thymic and pineal-derived short peptides to evaluate synergistic or comparative efficacy.

For example, Epithalon (Ala-Glu-Asp-Gly) is a tetrapeptide primarily studied for its capacity to induce telomerase activity and regulate pineal melatonin synthesis, whereas Vilon acts rapidly and directly on T-cell chromatin dynamics. Simultaneously, complex polypeptide mixtures such as Thymalin research overview contain a broader spectrum of native thymic factors, but present higher batch-to-batch variability compared to synthetic Vilon. Another frequently studied synthetic immune agent is Thymosin Alpha-1, a 28-amino-acid peptide that targets toll-like receptors (TLRs) and dendritic cell maturation. Compared to larger peptides, Vilon's small molecular size (Lys-Glu) offers distinct experimental advantages in rapid nuclear entry, synthetic purity, and low immunogenicity in culture.

Laboratory Reconstitution and Handling Protocols for Cell Culture Assays

Achieving consistent quantitative outcomes in lymphocyte proliferation and gene expression assays requires standardizing peptide reconstitution and dilution procedures. High-purity Vilon is supplied as a lyophilized white powder that must be handled under sterile conditions within a laminar flow biosafety cabinet.

For cell culture applications, lyophilized Vilon should be reconstituted in sterile, endo-free Phosphate-Buffered Saline (PBS, pH 7.4) or sterile Ultra-Pure Water (18.2 MΩ cm resistivity). Reconstitution directly into complete media containing fetal bovine serum (FBS) is generally discouraged for initial stock preparation, as uncharacterized serum proteins can bind or degrade short dipeptides prior to targeted assay administration.

A standard protocol involves creating a primary stock solution at a concentration of 1 mg/mL to 10 mg/mL. Once dissolved by gentle inversion—avoiding vigorous vortexing or sonic agitation that could alter peptide solubility—stock solutions should be filtered through a 0.22 µm low-protein-binding PVDF membrane filter. Working aliquots should be diluted into culture media to achieve target experimental concentrations, typically ranging from 10 nM to 1 µM depending on the sensitivity of the lymphocyte assay system.

Analytical Purity Benchmarks: HPLC, LC-MS, and Endotoxin Limits

When conducting sensitive cell culture research, the physical quality of the research compound directly impacts data validity. Impurities such as unreacted amino acid precursors, truncated peptides, organic solvents (acetonitrile, TFA), or heavy metals can cause off-target cellular toxicity, altering lymphocyte viability and gene expression profiles.

PX1 Research enforces stringent analytical criteria for all batches of Vilon before release. Verification standards include:

1. Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC): Ensures purity exceeds 98.0% by peak area integration, confirming the absence of related peptide contaminants.

2. Liquid Chromatography-Mass Spectrometry (LC-MS): Confirms exact molecular mass (275.3 g/mol) and fragment ion spectra, verifying sequence identity without chemical modifications.

3. Endotoxin Quantitation (LAL Assay): Essential for lymphocyte activity assays, endotoxin levels are verified to be below 0.1 EU/mg. Standard commercial peptides containing high endotoxin levels can inadvertently activate Toll-like Receptor 4 (TLR4) on immune cells, producing false-positive activation results.

Researchers can inspect individual lot certificates on our laboratory research hub prior to purchasing to verify strict compliance with these physical parameters.

Storage Parameters and Degradation Prevention

Short dipeptides like Vilon are structurally stable in dry lyophilized form but remain susceptible to hydrolysis and microbial degradation once exposed to moisture or ambient temperatures over extended periods.

Lyophilized Vilon should be stored in a dark, desiccated environment at -20°C for short-to-medium term storage (up to 12 months) or -80°C for long-term preservation. Prior to opening the vial, allow the container to equilibrate to room temperature (20°C to 25°C) to prevent atmospheric condensation from accumulating on the lyophilized cake.

Reconstituted liquid stock solutions stored at 4°C are stable for up to 7–14 days. For extended experimental timelines, reconstituted stock solutions should be divided into single-use aliquots and frozen at -20°C or -80°C to avoid repeated freeze-thaw cycles, which can hydrolyze peptide bonds and decrease effective molar concentrations over time.

Sourcing Standards: Why PX1 Research is the Preferred Vendor

Acquiring high-purity Vilon for lymphocyte research requires a supply partner dedicated to transparency, lot traceability, and strict quality control. PX1 Research operates state-of-the-art facilities located in California and Arizona, providing American-manufactured, fully characterized peptides designed strictly for academic, biotechnology, and institutional research laboratories.

Every batch of Vilon dispatched by PX1 Research includes a comprehensive, downloadable Certificate of Analysis (COA) detailing RP-HPLC chromatograms, mass spec analysis, and endotoxin assay reports. Orders placed Monday through Friday before cut-off times qualify for same-day dispatch, minimizing transit time and thermal stress on sensitive peptides. Laboratories seeking large-scale quantities or institutional account setup can explore our bulk research account application for specialized volume supply.